Professional Documents
Culture Documents
Drug Study Generic/ Brand Name Action Classification Indication Contraindicatio N Side Effects Nursing Intervention
Drug Study Generic/ Brand Name Action Classification Indication Contraindicatio N Side Effects Nursing Intervention
Generic/ Brand
Name
Ampicillin
Action
Classification
Inhibits the
Anti-infective
bacterial enzyme
transpeptidase
thus preventing
crosslinking cell
wall components
Purulent
meningitis in
neonates and
infants: 75
mg/kg QID.
Misoprostol
Reduces gastric
acid secretion
and increases
gastric mucus
and bicarbonate
production
Adults: 200mcg
QID with food,
with last daily
dose given at
bed time.
Anti-ulcerative;
cytoprotective
agent
Indication
Contraindicatio
n
Hypersensitivity
to penicillins;
infectious
mononucleosis
PProstaglandin
hypersensitivity;
pregnancy
Side Effects
Nursing
Intervention
GI disturbance,
Watch for
laryngeal stridor, bleeding
fever, sore
tendency and
mouth or tongue, hemorrhage.
superinfection
Monitor for
signs and
symptoms of
hypersensitivity
reaction.
Check for signs
and symptoms of
infection at
injection site.
Headache,
Assess GI status.
nausea,
Report
vomiting,
significant
diarrhea,
adverse
abdominal pain, reactions.
miscarriage,
Monitor
menstrual
menstrual
disorders
pattern or post
menstrual
building.
Report
significant
problems.
Oxytocin
Thought to
directly
stimulate
smooth muscle
contractions in
uterus and
cervix
Uterine-active
agent
To induce or
stimulate labor.
Adults: Initially,
1ml ampule in
compatible I.V.
solution infused
at 1 to 2
milliunits/
minute. Increase
rate in
increments of 1
to 2 milliunits/
minute q15 to 30
minutes until
acceptable
contraction
pattern is
established.
-Hypersensitivity
to drug
-Cephalopelvic
disproportion
-Fetal distress
when delivery is
not imminent
-prolonged use in
uterine inertia or
severe toxemia
Nausea,
vomiting,
premature
ventricular
contractions
Methergine
Directly
stimulates
vascular muscle
and contractions
in uterus and
cervix and
decreases
bleeding after
delivery.
Oxytocic
Prevention and
treatment of post
partum
hemorrhage.
Adults: 0.2
mgI.M.; repeat
q2 to 4 hours as
needed to a total
of five doses.
-hypersensitivity
to drugs
-hypertension
-toxemia
-pregnancy
Dizziness,
headache,
hallucination,
hypertension,
hypotension,
palpitations,
tinnitus, nausea,
diarrhea,
hematuria
Monitor
contractions,
fetal and
maternal heart
rate and
maternal blood
pressure and
ECG.
Monitor patient
extremely
closely during
the first and
second stages of
labor because of
risk of cervical
laceration.
Assess fluid
intake and
output.
Monitor patient
for adverse
effects. When
giving I.V.
closely monitor
blood pressure,
pulse, uterine
contractions and
bleeding.